DNA methylation profiles of ovarian epithelial carcinoma tumors and cell lines.
about
Identification of a CpG island methylator phenotype that defines a distinct subgroup of gliomaTumor hypomethylation at 6p21.3 associates with longer time to recurrence of high-grade serous epithelial ovarian cancerPromoter methylation in head and neck squamous cell carcinoma cell lines is significantly different than methylation in primary tumors and xenograftsGenome-scale screen for DNA methylation-based detection markers for ovarian cancerReducing confounding and suppression effects in TCGA data: an integrated analysis of chemotherapy response in ovarian cancer.Recursively partitioned mixture model clustering of DNA methylation data using biologically informed correlation structuresA genome-wide DNA methylation study in colorectal carcinoma.A novel method for identification and quantification of consistently differentially methylated regionsHuman endometrial DNA methylome is cycle-dependent and is associated with gene expression regulationA beta-mixture model for dimensionality reduction, sample classification and analysis.Progression-free survival in ovarian cancer is reflected in epigenetic DNA methylation profiles.Differential analysis of ovarian and endometrial cancers identifies a methylator phenotypeDistinct DNA methylation profiles in ovarian serous neoplasms and their implications in ovarian carcinogenesis.Genomic insights into cancer-associated aberrant CpG island hypermethylationHypermethylation of multiple tumor-related genes associated with DNMT3b up-regulation served as a biomarker for early diagnosis of esophageal squamous cell carcinomaTranslational genomics: the challenge of developing cancer biomarkers.Supratentorial and spinal pediatric ependymomas display a hypermethylated phenotype which includes the loss of tumor suppressor genes involved in the control of cell growth and death.Epigenetic determinants of ovarian clear cell carcinoma biology.Challenges in pre-clinical testing of anti-cancer drugs in cell culture and in animal modelsEpigenetic analysis of sporadic and Lynch-associated ovarian cancers reveals histology-specific patterns of DNA methylation.Repeated assessment by high-throughput assay demonstrates that sperm DNA methylation levels are highly reproduciblePromoter methylation status of HIN-1 associated with outcomes of ovarian clear cell adenocarcinoma.Epigenome-wide ovarian cancer analysis identifies a methylation profile differentiating clear-cell histology with epigenetic silencing of the HERG K+ channelExtracting coordinated patterns of DNA methylation and gene expression in ovarian cancer.Effects of 5-Aza-2'-deoxycytidine on the methylation state and function of the WWOX gene in the HO-8910 ovarian cancer cell lineGenome-wide methylation profiling of ovarian cancer patient-derived xenografts treated with the demethylating agent decitabine identifies novel epigenetically regulated genes and pathways.Pathway modulations and epigenetic alterations in ovarian tumorbiogenesis.Hypomethylation signature of tumor-initiating cells predicts poor prognosis of ovarian cancer patients.Targeting the epigenome in ovarian cancer.Cell surface protein glycosylation in cancer.Clinical importance and therapeutic implication of E-cadherin gene methylation in human ovarian cancer.Integrative DNA methylation and gene expression analysis in high-grade soft tissue sarcomasEpigenetic biomarkers in the diagnosis of ovarian cancer.γ-Glutamyl hydrolase modulation significantly influences global and gene-specific DNA methylation and gene expression in human colon and breast cancer cells.A statistical framework for Illumina DNA methylation arrays.Differentially methylated loci distinguish ovarian carcinoma histological types: evaluation of a DNA methylation assay in FFPE tissue.Bridging the divide: preclinical research discrepancies between triple-negative breast cancer cell lines and patient tumors.Distinct methylation profile of mucinous ovarian carcinoma reveals susceptibility to proteasome inhibitors.A methylation-specific dot blot assay for improving specificity and sensitivity of methylation-specific PCR on DNA methylation analysis.Estrogen receptor promoter methylation predicts survival in low-grade ovarian carcinoma patients.
P2860
Q24612429-18F1C7BA-64FA-4D03-ABC3-B83BDB2427CFQ28238067-C81DB9A5-D979-48C9-9721-1A1761BF30E4Q28478302-9DFF5F72-B5D1-42DC-8FCE-DC00D30E3E8CQ28741759-A5BA4CA4-742E-421E-85C3-5C957F627590Q30576727-FF6B6968-FCE8-451E-9AD7-1A15713EDEF2Q30596981-E2A96810-B42E-4B81-B984-A5EEA51B7141Q31020320-86D86FBA-01D6-4D8F-BF19-82FB52AF81D0Q33599244-6FB6EFAF-5B72-43E6-B222-9AF76CFA1F48Q33821591-508FBD2C-DEED-4BD9-80DA-C083693E4FE3Q33914431-1BEA0274-0444-4210-B9F2-FFDAD0D36AA4Q34185403-72CAF3C7-D88F-46C3-982C-0C9C718A5AB1Q34189765-14B9A0D5-8087-4CC6-87A9-17A297743BD3Q34361640-62A39968-CF2A-48C4-9E40-CA18DE33BBF4Q34647477-BF6C75BA-63E1-4E73-B045-96EE30A01820Q34974989-06D5FBC9-FB7A-4235-8CE9-B4A8FF7E045BQ35694362-F3E8D275-9D0F-40FF-8107-FB0E0465D5FEQ35863933-5D953348-747C-411C-8DD7-04B43158E046Q35908353-890EC605-D1A2-4501-9415-809DFD8988F9Q36070093-58FCD5E8-041B-44DC-A5BB-DEDDEA71C727Q36213561-38FA4E83-4825-412B-BCCF-F12B5C9BCBFBQ36251573-031047D1-0C94-49A9-B0AD-9C09C14D8873Q36462879-8E8BC915-21A0-4700-8A33-5840D4B3961AQ36975149-6BE028A0-F4EE-4298-9298-9D20E2B6AFDEQ37039919-272C4810-19F9-417D-9634-013838578F2CQ37211635-8029C3CB-D16F-43C4-A1F6-1ECFA3A5EABFQ37353774-F9F10B31-5D96-4918-B777-E5D6FA8F1FE8Q37420213-196ED1F6-C148-4DD3-9BB9-B8361E839ED3Q37619308-B1B4E2FD-8F59-426B-A0F3-8A4C3604A807Q37984122-FD92F733-4836-4502-9124-ACA3752DA250Q38171440-194AE607-323A-457E-A824-EADE69453BFCQ38980070-E6AFFE9E-D07C-4E4A-B287-199D15CF4511Q39042581-8A903FDC-BEFC-43C7-A88D-57FB0CFBADEFQ39453522-F245D838-A29A-4832-8B8C-1CB0BA6EE7B1Q41696626-AFA54C23-E050-427A-918E-D85679FC5A2BQ42578397-73B35CBA-70CB-4CD5-B24F-966834D35266Q42662678-E715DD29-326F-4845-B9A2-F3F6F118B967Q49619782-0E545DE5-A69C-45BD-BA8C-2C31DA9D5D02Q49937490-A628A9BA-1904-4DAC-9DCC-76334CC47945Q53640792-7CE5D75C-5645-447D-9FCC-53C3AB3E577FQ54204521-CC5C7080-07B4-4D5F-B29D-4C78ED2F1909
P2860
DNA methylation profiles of ovarian epithelial carcinoma tumors and cell lines.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
DNA methylation profiles of ovarian epithelial carcinoma tumors and cell lines.
@ast
DNA methylation profiles of ovarian epithelial carcinoma tumors and cell lines.
@en
DNA methylation profiles of ovarian epithelial carcinoma tumors and cell lines.
@nl
type
label
DNA methylation profiles of ovarian epithelial carcinoma tumors and cell lines.
@ast
DNA methylation profiles of ovarian epithelial carcinoma tumors and cell lines.
@en
DNA methylation profiles of ovarian epithelial carcinoma tumors and cell lines.
@nl
prefLabel
DNA methylation profiles of ovarian epithelial carcinoma tumors and cell lines.
@ast
DNA methylation profiles of ovarian epithelial carcinoma tumors and cell lines.
@en
DNA methylation profiles of ovarian epithelial carcinoma tumors and cell lines.
@nl
P2093
P2860
P1433
P1476
DNA methylation profiles of ovarian epithelial carcinoma tumors and cell lines.
@en
P2093
Aviva P Ventura
Beatrice S Knudsen
Chana Palmer
Charles W Drescher
Mari N Olsen
Mihaela Campan
Nicole D Urban
Peter W Laird
Sahar Houshdaran
Sarah Hawley
P2860
P356
10.1371/JOURNAL.PONE.0009359
P407
P577
2010-02-22T00:00:00Z